Analyst Activity – Mizuho Reiterates Buy on NASDAQ:FGEN – FibroGen (NASDAQ:FGEN)

Analyst Ratings For NASDAQ:FGEN – FibroGen (NASDAQ:FGEN)

Story continues below

Today, Mizuho reiterated its Buy rating on NASDAQ:FGEN – FibroGen (NASDAQ:FGEN) with a price target of $61.00.

Some recent analyst ratings include

  • 6/1/2018-Mizuho Reiterated Rating of Buy.
  • 2/28/2018-Leerink Swann Reiterated Rating of Outperform.
  • 9/14/2017-Stifel Nicolaus Reiterated Rating of Buy.
  • 9/12/2017-Jefferies Group Reiterated Rating of Buy.
  • 8/9/2017-William Blair Reiterated Rating of Outperform.
  • 7/21/2017-Goldman Sachs Group was Downgraded by analysts at Goldman Sachs Group from a “Buy ➝ Neutral” rating to a “” rating. They now have a $31.00 price target on the stock.

Recent Insider Trading Activity For NASDAQ:FGEN – FibroGen (NASDAQ:FGEN)
NASDAQ:FGEN – FibroGen (NASDAQ:FGEN) has insider ownership of 8.96% and institutional ownership of 63.47%.

  • On 5/21/2018 Pat Cotroneo, SVP, sold 14,987 with an average share price of $55.04 per share and the total transaction amounting to $824,884.48.
  • On 5/17/2018 Kalevi Kurkijarvi, Director, sold 4,000 with an average share price of $51.83 per share and the total transaction amounting to $207,320.00.
  • On 5/17/2018 Thomas B Neff, CEO, sold 39,636 with an average share price of $51.82 per share and the total transaction amounting to $2,053,937.52.
  • On 5/9/2018 Jorma Routti, Director, sold 6,000 with an average share price of $47.10 per share and the total transaction amounting to $282,600.00.
  • On 5/3/2018 Thomas B Neff, CEO, sold 39,636 with an average share price of $47.04 per share and the total transaction amounting to $1,864,477.44.
  • On 4/19/2018 Kalevi Kurkijarvi, Director, sold 4,000 with an average share price of $47.69 per share and the total transaction amounting to $190,760.00.
  • On 4/18/2018 Thomas B Neff, CEO, sold 39,636 with an average share price of $48.56 per share and the total transaction amounting to $1,924,724.16.

Recent Trading Activity for NASDAQ:FGEN – FibroGen (NASDAQ:FGEN)
Shares of NASDAQ:FGEN – FibroGen closed the previous trading session at 53.80 down -0.10 0.19% with 53.79999923706055 shares trading hands.

An ad to help with our costs